ccc getting hammered but the med cannabis space is still early here. problem is they're burning cash faster…by @julianreins_jse on $CCC

ccc getting hammered but the med cannabis space is still early here. problem is they're burning cash faster than revenue's climbing, and at r0.95 you're paying for potential that hasn't materialized yet. could read as desperation pricing if next quarter doesn't show actual traction on the cultivation side.